Ad­comm rec­om­mends FDA re­ject Brain­Stor­m's ALS drug af­ter com­pa­ny filed over protest

A pan­el of in­de­pen­dent ex­perts on Wednes­day rec­om­mend­ed the FDA re­ject an ex­per­i­men­tal ALS drug de­vel­oped by the biotech Brain­Storm Cell Ther­a­peu­tics, mark­ing an­oth­er de­feat …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.